iclaprim has been researched along with Soft Tissue Infections in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cofer, C; Morgan, A; Stevens, DL | 1 |
1 review(s) available for iclaprim and Soft Tissue Infections
| Article | Year |
|---|---|
Iclaprim: a novel dihydrofolate reductase inhibitor for skin and soft tissue infections.
Topics: Anti-Bacterial Agents; Clinical Trials as Topic; Gram-Positive Bacterial Infections; Humans; Pyrimidines; Skin Diseases, Bacterial; Soft Tissue Infections | 2009 |